Laverock Therapeutics Seed
33 employees on LinkedIn · 4 known investors
Laverock develops programmable engineered cell therapies that control gene expression based on cell identity and environment, activating only in the target cell population and tuning expression to precise levels. The company applies its gene-regulation platforms to an internal advanced therapy pipeline and pursues outlicensing and partnerships for additional therapeutic and non-therapeutic applications.
Investors · 4
Frequently asked questions
- What does Laverock Therapeutics Seed do?
- Laverock develops programmable engineered cell therapies that control gene expression based on cell identity and environment, activating only in the target cell population and tuning expression to precise levels. The company applies its gene-regulation platforms to an internal advanced therapy pipeline and pursues outlicensing and partnerships for additional therapeutic and non-therapeutic applications.
- Who are Laverock Therapeutics Seed's investors?
- Laverock Therapeutics Seed's investors include Eos Advisory, Future Planet Capital, Tekfen Ventures, UK Innovation & Science Seed Fund.